NEJM

In adults with myasthenia gravis, treatment with intravenous inebilizumab, a CD19-specific monoclonal antibody, significantly improved function and reduced disease severity […]

A 34-year-old man was admitted to the hospital because of left ear pain with hearing loss and facial droop on

The field of pulmonary fibrosis has come a long way in the past 25 years, with the approach to patient

In this randomized, placebo-controlled trial involving patients with giant-cell arteritis, the oral Janus kinase inhibitor upadacitinib (15 mg) significantly improved